Drape Eric 4
4 · TEVA PHARMACEUTICAL INDUSTRIES LTD · Filed Mar 7, 2024
Insider Transaction Report
Form 4
Drape Eric
Executive VP Global Operations
Transactions
- Exercise/Conversion
Ordinary Shares
2024-03-05+22,576→ 90,689 total - Exercise/Conversion
Restricted Share Units
2024-03-05−22,576→ 22,576 total→ Ordinary Shares (22,576 underlying) - Exercise/Conversion
Restricted Share Units
2024-03-05−55,226→ 0 total→ Ordinary Shares (55,226 underlying) - Exercise/Conversion
Ordinary Shares
2024-03-05+55,226→ 145,915 total
Footnotes (5)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
- [F3]Amount reflects the sale of 9,815 Ordinary Shares by the Reporting Person, as reported in a Form 4 filed on March 1, 2024, which was inadvertently omitted from the amount of securities beneficially owned by the Reporting Person following the transactions reported in a Form 4 filed on March 5, 2024.
- [F4]Restricted share units were granted on March 5, 2021, with 22,576 vested on March 5, 2022, March 5, 2023, March 5, 2024 and 22,576 vesting on March 5, 2025.
- [F5]Restricted share units were granted on January 30, 2024 pursuant to the satisfaction of performance criteria and vested on March 5, 2024.